C. Bachier

发表

Infusional Vinorelbine in Relapsed or Refractory Lymphomas

P. Mclaughlin, A. Psyrri, L. Medeiros, 2000, Leukemia & lymphoma.

The impact of early versus late tocilizumab administration in patients with cytokine release syndrome secondary to immune effector cell therapy

I. Flinn, M. Battiwalla, W. Donnellan, 2021, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Single and multiple dose MultiStem (multipotent adult progenitor cell) therapy prophylaxis of acute graft-versus-host disease in myeloablative allogeneic hematopoietic cell transplantation: a phase 1 trial.

H. Lazarus, S. Devine, R. Maziarz, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Phase 1 Study of NKX101, an Allogeneic CAR Natural Killer (NK) Cell Therapy, in Subjects with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-Risk Myelodysplastic Syndrome (MDS)

S. Nikiforow, G. Borthakur, K. Rajangam, 2020 .

Ninety-six-hour paclitaxel infusion with mitoxantrone and ifosfamide/mesna and consolidation with ESHAP for refractory and relapsed non-Hodgkin's lymphoma.

P. Mclaughlin, F. Cabanillas, A. Sarris, 1998, Leukemia & lymphoma.

Paclitaxel plus high‐dose cyclosphosphamide with G‐CSF support in patients with relapsed and refractory aggressive non‐Hodgkin's lymphoma

P. Mclaughlin, F. Cabanillas, A. Younes, 1998, British journal of haematology.

Immunotoxin Therapy of Cancer

C. Bachier, Dr C. Frederick LeMaistre, 1995, Clinical Immunotherapeutics.

Increased Foxp3+Helios+ Regulatory T Cells and Decreased Acute Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation in Patients Receiving Sirolimus and RGI-2001, an Activator of Invariant Natural Killer T Cells.

Y. Ishii, Y. Efebera, L. Lekakis, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease

J. Weiss, Stephanie J. Lee, O. Schueller, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

State-of-the-Art Review Ex Vivo-Expanded Hematopoietic Cell Graft Recipients Exhibit T Cell Repertoire Diversity Similar to That Seen After Conventional Stem Cell Transplants

E. Gokmen, J. Teale, C. Bachier, 2001 .

Ex vivo-expanded hematopoietic cell graft recipients exhibit T cell repertoire diversity similar to that seen after conventional stem cell transplants.

E. Gokmen, J. Teale, C. Bachier, 2001, Journal of hematotherapy & stem cell research.

Ex-vivo expansion of bone marrow progenitor cells for hematopoietic reconstitution following high-dose chemotherapy for breast cancer.

E. Shpall, E. Gokmen, J. Teale, 1999, Experimental hematology.

Association between takotsubo cardiomyopathy and axitinib: case report and review of the literature.

D. Ovadia, Y. Esquenazi, C. Bachier, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prophylaxis of Acute GVHD Using Multistem® Stromal Cell Therapy: Preliminary Results After Administration of Single or Multiple Doses in a Phase 1 Trial

H. Lazarus, R. Maziarz, Robert Perry, 2012 .

Prophylaxis of Acute Gvhd Using Stromal Cell Therapy: Preliminary Results After Administration of Single or Multiple Doses of Multistem® in a Phase I Trial

H. Lazarus, R. Maziarz, Robert Perry, 2011 .

Stromal Stem Cell Therapy for Prophylaxis of Acute GVHD: Preliminary Results From a Phase 1 Trial

H. Lazarus, S. Devine, R. Maziarz, 2011 .

Endpoints for Clinical Trials Testing Treatment of Acute Graft- versus-host Disease: A Consensus Document

R. Soiffer, P. McCarthy, M. MacMillan, 2010 .

Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement.

E. Shpall, R. Soiffer, P. McCarthy, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy.

P. Thall, G. Hortobagyi, R. Giles, 1996, Proceedings of the National Academy of Sciences of the United States of America.

A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantation

P. Stiff, A. Pecora, S. Goldberg, 2001, Bone Marrow Transplantation.

Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study

A. Logan, D. Howard, J. Liesveld, 2021, Blood.

Gene therapy of solid tumors and hematopoietic neoplasms.

A. Deisseroth, C. Bachier, 1997, Cancer treatment and research.

Granulocyte Colony‐Stimulating Factor Mobilizes More Dendritic Cell Subsets Than Granulocyte‐Macrophage Colony‐Stimulating Factor with No Polarization of Dendritic Cell Subsets in Normal Donors

Y. Gazitt, P. Shaughnessy, C. Bachier, 2006, Stem cells.

Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancer.

S. Heimfeld, M. Andreeff, R. Giles, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Once daily busulfan cyclophosphamide is well tolerated and effective as a preparative regimen for allogeneic hematopoietic stem cell transplant

P. Shaughnessy, C. Lemaistre, C. Bachier, 2012, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Efficacy of Fluconazole Prophylaxis for Autologous Peripheral Blood Stem Cell Transplantation: Results of a Prospective, Randomized, Controlled, Multicenter, Open Label Study.

N. Callander, C. Freytes, P. Shaughnessy, 2004 .

Paclitaxel activity for the treatment of non‐Hodgkin's lymphoma: final report of a phase II trial

R. Kurzrock, P. Mclaughlin, L. North, 1997, British journal of haematology.

Valganciclovir for the prophylaxis of cytomegalovirus infection early after allogenic stem cell transplantation

N. Callander, C. Freytes, P. Shaughnessy, 2011 .

Tbo-Filgrastim versus Filgrastim during Mobilization and Neutrophil Engraftment for Autologous Stem Cell Transplantation.

P. Shaughnessy, C. Bachier, J. Magraner, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Epidemiology and Treatment of Chronic Graft-versus-Host Disease Post-Allogeneic Hematopoietic Cell Transplantation: A US Claims Analysis.

K. Francis, C. Bachier, S. Dehipawala, 2020, Transplantation and cellular therapy.

Epidemiology and Real-World Treatment of Chronic Graft-Versus-Host Disease Post Allogeneic Hematopoietic Cell Transplantation: A US Claims Analysis

K. Francis, C. Bachier, M. Rotta, 2019, Blood.

The Other Side of CAR T-Cell Therapy: Cytokine Release Syndrome, Neurologic Toxicity, and Financial Burden.

K. Rezvani, E. Shpall, J. Westin, 2019, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

The presence of the Rb c-box peptide in the cytoplasm inhibits p210bcr-abl transforming function

C. Balagué, D. Kufe, G. Randhawa, 1999, Oncogene.

The Transcription Factor Wilms Tumor 1 Confers Resistance in Myeloid Leukemia Cells against the Proapoptotic Therapeutic Agent TRAIL (Tumor Necrosis Factor α-related Apoptosis-inducing Ligand) by Regulating the Antiapoptotic Protein Bcl-xL*

G. Tomlinson, M. Rao, S. Iyer, 2012, The Journal of Biological Chemistry.

Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10+ advanced non-small cell lung cancer

Matthew J. Frigault, R. Govindan, Melissa L. Johnson, 2022, Journal for ImmunoTherapy of Cancer.

Adoptive Cellular Therapy in Acute Myeloid Leukemia: Current Scope and Challenges.

N. Majhail, Palash Asawa, C. Bachier, 2022, Hematology/oncology and stem cell therapy.

Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma.

P. Mclaughlin, J. Cox, F. Cabanillas, 1998, Blood.

High white blood cell concentration in the peripheral blood stem cell product can induce seizures during infusion of autologous peripheral blood stem cells.

K. Chan, V. Jude, P. Shaughnessy, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host disease.

N. Callander, N. Flomenberg, J. Essell, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Ig heavy chain CDR3 size diversities are similar after conventional peripheral blood and ex vivo expanded hematopoietic cell transplants

E. Gokmen, C. Lemaistre, C. Bachier, 2001, Bone Marrow Transplantation.

Phase II study of a moderate-intensity preparative regimen with allogeneic peripheral blood stem cell transplantation for hematologic diseases: the Texas Transplant Consortium experience.

N. Callander, J. Anderson, C. Freytes, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial

G. Papanicolaou, J. Mehta, J. Panse, 2018, The Lancet.

Graft failure in a patient with systemic lupus erythematosus (SLE) treated with high-dose immunosuppression and autologous stem cell rescue

S. Lanzkron, C. Bachier, B. Kissack, 2001, Bone Marrow Transplantation.

Precision-Engineered Cell Therapy Orca-T Demonstrates High Relapse-Free Survival at 1 Year While Reducing Graft-Versus-Host Disease and Toxicity

R. Negrin, L. Muffly, E. Meyer, 2022, Blood.

Budget impact analysis of belumosudil for chronic graft-versus-host disease treatment in the United States

Jeffrey R. Skaar, J. Skaar, C. Bachier, 2021, Journal of medical economics.

Survival outcomes of allogeneic hematopoietic cell transplants with EBV‐positive or EBV‐negative post‐transplant lymphoproliferative disorder, A CIBMTR study

P. Hari, V. Brown, H. Heslop, 2019, Transplant infectious disease : an official journal of the Transplantation Society.

Paclitaxel (Taxol) for the treatment of lymphoma.

L. North, F. Cabanillas, A. Younes, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.